Previous close | 5.65 |
Open | 3.45 |
Bid | 10.70 |
Ask | 11.00 |
Strike | 124.00 |
Expiry date | 2024-05-31 |
Day's range | 9.70 - 10.87 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.